Delta-like 1-Lysine613 Regulates Notch Signaling

di Zhang, Liguo, Widau, Ryan C., Herring, B. Paul, Gallagher, Patricia J.
Pubblicazione 2011

Protein Phosphatase 2A (PP2A) Holoenzymes Regulate Death-associated Protein Kinase (DAPK) in Ceramide-induced Anoikis

di Widau, Ryan C., Jin, Yijun, Dixon, Shelley A., Wadzinski, Brian E., Gallagher, Patricia J.
Pubblicazione 2010

p19(Arf) Represses Platelet-Derived Growth Factor Receptor β by Transcriptional and Posttranscriptional Mechanisms

di Widau, Ryan C., Zheng, Yanbin, Sung, Caroline Y., Zelivianskaia, Anna, Roach, Lauren E., Bachmeyer, Karen M., Abramova, Tatiana, Desgardin, Aurelie, Rosner, Andrew, Cunningham, John M., Skapek, Stephen X.
Pubblicazione 2012

Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF)

di Arkenau, Hendrik‐Tobias, Martin‐Liberal, Juan, Calvo, Emiliano, Penel, Nicolas, Krebs, Matthew G., Herbst, Roy S., Walgren, Richard A., Widau, Ryan C., Mi, Gu, Jin, Jin, Ferry, David, Chau, Ian
Pubblicato in Oncologist (2018)

Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab

di Reig, Maria, Galle, Peter R., Kudo, Masatoshi, Finn, Richard, Llovet, Josep M., Metti, Andrea L., Schelman, William R., Liang, Kun, Wang, Chunxiao, Widau, Ryan C., Abada, Paolo, Zhu, Andrew X.
Pubblicato in Liver Int (2020)

STING promotes homeostasis via regulation of cell proliferation and chromosomal stability

di Ranoa, Diana Rose E., Widau, Ryan C., Mallon, Stephen, Parekh, Akash D., Nicolae, Claudia M., Huang, Xiaona, Bolt, Michael J., Arina, Ainhoa, Parry, Renate, Kron, Stephen J., Moldovan, George-Lucian, Khodarev, Nikolai N., Weichselbaum, Ralph R.
Pubblicato in Cancer Res (2018)

RIG-I–like receptor LGP2 protects tumor cells from ionizing radiation

di Widau, Ryan C., Parekh, Akash D., Ranck, Mark C., Golden, Daniel W., Kumar, Kiran A., Sood, Ravi F., Pitroda, Sean P., Liao, Zhengkai, Huang, Xiaona, Darga, Thomas E., Xu, David, Huang, Lei, Andrade, Jorge, Roizman, Bernard, Weichselbaum, Ralph R., Khodarev, Nikolai N.
Pubblicazione 2014

Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab

di Zhu, Andrew X., Finn, Richard S., Kang, Yoon-Koo, Yen, Chia-Jui, Galle, Peter R., Llovet, Josep M., Assenat, Eric, Brandi, Giovanni, Motomura, Kenta, Ohno, Izumi, Daniele, Bruno, Vogel, Arndt, Yamashita, Tatsuya, Hsu, Chih-Hung, Gerken, Guido, Bilbruck, John, Hsu, Yanzhi, Liang, Kun, Widau, Ryan C., Wang, Chunxiao, Abada, Paolo, Kudo, Masatoshi
Pubblicato in Br J Cancer (2021)

Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2

di Kudo, Masatoshi, Galle, Peter R., Brandi, Giovanni, Kang, Yoon-Koo, Yen, Chia-Jui, Finn, Richard S., Llovet, Josep M., Assenat, Eric, Merle, Philippe, Chan, Stephen L., Palmer, Daniel H., Ikeda, Masafumi, Yamashita, Tatsuya, Vogel, Arndt, Huang, Yi-Hsiang, Abada, Paolo B., Yoshikawa, Reigetsu, Shinozaki, Kenta, Wang, Chunxiao, Widau, Ryan C., Zhu, Andrew X.
Pubblicato in JHEP Rep (2020)